CCS
VIVS

Crosspoint Capital Strategies’s VivoSim Labs VIVS Stock Holding History

Crosspoint Capital Strategies’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2
Closed -$4K – 855
2015
Q4 		$4K Buy
+2
New +$1.45K ﹤0.01% 846
2014
Q2 		– Hold
0
– -$1K – 641
2014
Q1 		– Hold
0
– – – 662

Other funds holding VIVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Crosspoint Capital Strategies's VIVS Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of VivoSim Labs (VIVS) in Q1 2016, closing a stake of 2 shares — an estimated $4K sold.

Crosspoint Capital Strategies first reported a position in VIVS in Q4 2015 and held it in 1 quarter. The position peaked at $4K in Q4 2015. 109 funds tracked by Wall St. Rank hold VIVS as of Q1 2016.

  • Crosspoint Capital Strategies reported no remaining VivoSim Labs position as of Q1 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 2 VivoSim Labs shares in Q1 2016, an estimated $4K.
  • Crosspoint Capital Strategies first reported a position in VivoSim Labs in Q4 2015 and held it in 1 quarter.
  • Crosspoint Capital Strategies's VivoSim Labs position peaked at $4K in Q4 2015.
  • 109 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.